The endocrine and metabolic link between COVID-19, diabetes and obesity
Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome corona virus 2. High age, hypertension, diabetes, and obesity are risk factors for severe COVID-19 with increased mortality. In this review, we discuss potential mechanisms by which diabetes and obesity modulate the host viral interactions and host-immune response. Glucose levels should be monitored rigorously, and patient-tailored aggressive treatment of hyperglycaemia is recommended, often with the use of insulin. Persons with diabetes and obesity are susceptible to severe outcomes from COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:182 |
---|---|
Enthalten in: |
Ugeskrift for laeger - 182(2020), 29 vom: 13. Juli |
Sprache: |
Dänisch |
---|
Beteiligte Personen: |
Weis, Nina [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 06.08.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM313103798 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313103798 | ||
003 | DE-627 | ||
005 | 20231225145841.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||dan c | ||
028 | 5 | 2 | |a pubmed24n1043.xml |
035 | |a (DE-627)NLM313103798 | ||
035 | |a (NLM)32734864 | ||
035 | |a (PII)V05200381 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a dan | ||
100 | 1 | |a Weis, Nina |e verfasserin |4 aut | |
245 | 1 | 4 | |a The endocrine and metabolic link between COVID-19, diabetes and obesity |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.08.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome corona virus 2. High age, hypertension, diabetes, and obesity are risk factors for severe COVID-19 with increased mortality. In this review, we discuss potential mechanisms by which diabetes and obesity modulate the host viral interactions and host-immune response. Glucose levels should be monitored rigorously, and patient-tailored aggressive treatment of hyperglycaemia is recommended, often with the use of insulin. Persons with diabetes and obesity are susceptible to severe outcomes from COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Insulin |2 NLM | |
700 | 1 | |a Thorsteinsson, Kristina |e verfasserin |4 aut | |
700 | 1 | |a Martinussen, Christoffer |e verfasserin |4 aut | |
700 | 1 | |a Madsbad, Sten |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ugeskrift for laeger |d 1945 |g 182(2020), 29 vom: 13. Juli |w (DE-627)NLM000011185 |x 1603-6824 |7 nnns |
773 | 1 | 8 | |g volume:182 |g year:2020 |g number:29 |g day:13 |g month:07 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 182 |j 2020 |e 29 |b 13 |c 07 |